Antibodies

03 Jun 2008 Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combination With Velcade for Multiple Myeloma
03 Jun 2008 Trubion Announces Presentation of Positive TRU-016 Data at ASCO
03 Jun 2008 New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing’s Sarcoma
03 Jun 2008 Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
03 Jun 2008 Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer
02 Jun 2008 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
02 Jun 2008 New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
02 Jun 2008 Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
02 Jun 2008 Interim Phase 2 Results of Open-Label Clinical Trial of Denosumab in Giant Cell Tumor of Bone Demonstrated 87 Percent Response Rate
02 Jun 2008 CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
30 May 2008 Merck Receives CHMP Positive Opinion for Marketing Authorization for Erbitux Including First-Line Colorectal Cancer in the European Union
30 May 2008 Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer
30 May 2008 Genmab initiates Zalutumunab combination study in Colorectal Cancer
28 May 2008 Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial Versus Weekly Alendronate (FOSAMAX(R))
28 May 2008 Ablynx Announces Initiation of a Phase Ib Study in Patients for ALX-0081 and Provides a Business Update for the First Quarter 2008
21 May 2008 Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week
21 May 2008 Sanofi-aventis and Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program in Oncology
21 May 2008 Cimzia(R) provides long-term efficacy with stable dosing in Crohn's disease
20 May 2008 Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
20 May 2008 Phase I/II Studies of IMC-A12 in Pancreatic Cancer Open for Patient Enrollment
19 May 2008 Patient recruitment started in Phase III registration trial with CA9-SCAN
19 May 2008 Schering-Plough Extends Antibody Alliance with MorphoSys
16 May 2008 ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top